Treatment Registry
TR-0139 ActiveRecorded September 2026

Compounded semaglutide

Sold by RxION Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$99

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Semaglutide Compounded · recorded initial monthly payment$99

Added from the figures recorded below.

Price

TermPer monthCharged today
Semaglutide Compounded

“Starting at $199 $99 /month”

Per month$99Charged today$99
Price sources
Visit RxION Health

We earn nothing from this link. It opens RxION Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationBefore your renewal date: You may cancel at any time before your scheduled renewal at no charge. No payment will be taken.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from tryrxion.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — 'Starting at $199 $99 /month' and 'Starting at $299 $183 /month' show a struck-through original price beside a lower current price, printed together in that order in the visible text (the extractor drops HTML strikethrough styling, not the numbers). 'Price reflects consultation plus medication if prescribed' confirms these are program prices, not membership fees. States exclusion given per-product (NJ/AK/MS) rather than as a company-wide statement.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0139
Medication category
compounded semaglutide
Readings
1

Related records

Other records from RxION Health

All RxION Health programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). RxION Health — compounded semaglutide (TR-0139). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0139

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.